跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Clarithromycin Sustained Release Tablets
Approved
化学药品
Clarithromycin Sustained Release Tablets
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
🇨🇳 National Medical Products Administration
Approval Date
May 6, 2020
Approval ID
7MazXbWf7Xk
Company
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Type
化学药品
Approval Details
Approval Id
7MazXbWf7Xk
Approval Number
H20181041
Generic Name
克拉霉素缓释片
Generic Name En
Clarithromycin Sustained Release Tablets
Trade Name
克拉仙
Drug Type
化学药品
Dosage Form
片剂
Strength
0.5g
Reg Date
2020-05-06
Expired Date
2025-05-05
Company Name
ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Company Address
3 FRASER STREET #23-28 DUO TOWER SINGAPORE 189352
Production Company Name
AESICA QUEENBOROUGH LIMITED
Production Company Address
Queenborough, Kent, ME11 5EL, U.K.
Company Detail Path
/organization/abbott-laboratories-singapore-private-limited
Production Company Detail Path
/organization/aesica-queenborough-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 6, 2020
Approval ID
7MazXbWf7Xk
Type
化学药品
Back to NMPA Approvals
克拉仙 - NMPA Drug Approval Details